2nd Quarter - Report

THORN RUN PARTNERS for NOVARTIS CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 18, 2018 $60,000 Replaced
2nd Quarter - Amendment Jan 18, 2019 $50,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to biologics.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Neonatal drug issues.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Foreign Relations FOR

Legislation related to CFIUS and FARA including issues related to critical technologies and export controls; S.2098/H.R.4311, Foreign Investment Risk Review Modernization Act of 2017; S.2482, Foreign Agents Registration Amendments Act of 2018.

LobbyistCovered position, as disclosed
CHARLES B. THOMAS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2482 (115th), H.R. 4311 (115th), S. 2098 (115th)

Medicare/Medicaid MMM

Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to the Part D coverage gap and the Medicare reimbursement of biosimilars.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Issues related to the Orphan Drug Tax.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.